Modulator in MASH, MAFLD, liver fibrosis, and HCC. Conflicting roles in HCC development, with evidence suggesting both pro-tumorigenic and anti-tumorigenic effects. Promotion of angiogenesis via Src. Suppression of anti-tumor immunity. This evidence concerns the gene SRC and fibrosis.